Todd Lewis

622 total citations
13 papers, 178 citations indexed

About

Todd Lewis is a scholar working on Surgery, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Todd Lewis has authored 13 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 3 papers in Cellular and Molecular Neuroscience and 2 papers in Organic Chemistry. Recurrent topics in Todd Lewis's work include Lipoproteins and Cardiovascular Health (3 papers), Genetic Neurodegenerative Diseases (2 papers) and Viral Infections and Immunology Research (2 papers). Todd Lewis is often cited by papers focused on Lipoproteins and Cardiovascular Health (3 papers), Genetic Neurodegenerative Diseases (2 papers) and Viral Infections and Immunology Research (2 papers). Todd Lewis collaborates with scholars based in United States and United Kingdom. Todd Lewis's co-authors include Rebecca F. Goldfaden, Jessica Reid, Rushab Choksi, J. P. Mottershead, Khalid Hamandi, Nancy M. Frick, Cornelia Drees, Richard L. Bruno, Jerald R. Zimmerman and Sherif B. Mossad and has published in prestigious journals such as PLoS ONE, Neurology and Clinical Infectious Diseases.

In The Last Decade

Todd Lewis

11 papers receiving 171 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Todd Lewis United States 8 99 42 34 26 20 13 178
M. Picó Spain 11 55 0.6× 36 0.9× 50 1.5× 6 0.2× 17 0.8× 20 294
Sevilay Özmen Türkiye 8 39 0.4× 26 0.6× 13 0.4× 52 2.0× 12 0.6× 56 255
Ken Tsuchida Japan 9 115 1.2× 7 0.2× 68 2.0× 17 0.7× 53 2.6× 31 297
Jun Miao China 11 92 0.9× 103 2.5× 13 0.4× 15 0.6× 63 3.1× 41 267
Jefferson M. Lyons United States 10 93 0.9× 44 1.0× 60 1.8× 8 0.3× 48 2.4× 18 231
Dorota Lebiedz‐Odrobina United States 4 35 0.4× 10 0.2× 38 1.1× 28 1.1× 13 0.7× 10 166
Kilimangalam Narayanan United Kingdom 4 60 0.6× 13 0.3× 14 0.4× 42 1.6× 39 1.9× 7 217
Sara Chalifoux United States 8 173 1.7× 51 1.2× 9 0.3× 4 0.2× 14 0.7× 10 314
J Lonovics Hungary 9 76 0.8× 66 1.6× 46 1.4× 2 0.1× 32 1.6× 26 252
Velota Sung United Kingdom 14 21 0.2× 38 0.9× 26 0.8× 24 0.9× 36 1.8× 32 564

Countries citing papers authored by Todd Lewis

Since Specialization
Citations

This map shows the geographic impact of Todd Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Lewis more than expected).

Fields of papers citing papers by Todd Lewis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Lewis. The network helps show where Todd Lewis may publish in the future.

Co-authorship network of co-authors of Todd Lewis

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Lewis. A scholar is included among the top collaborators of Todd Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Lewis. Todd Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hardy, Jennifer, Edward Pereira, Todd Lewis, et al.. (2021). A Critical Review of the Efficacy and Safety of Inclisiran. American Journal of Cardiovascular Drugs. 21(6). 629–642. 32 indexed citations
2.
Reid, Jessica, et al.. (2020). Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention. American Journal of Cardiovascular Drugs. 20(5). 419–429. 2 indexed citations
3.
Reid, Jessica, et al.. (2020). A Review of the Efficacy and Tolerability of Bempedoic Acid in the Treatment of Hypercholesterolemia. American Journal of Cardiovascular Drugs. 20(6). 535–548. 23 indexed citations
4.
Reid, Jessica, et al.. (2019). <p>A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 1897–1911. 7 indexed citations
5.
Newberg, Andrew B., Mijail D. Serruya, Charles Intenzo, et al.. (2014). Clinical Comparison of 99mTc Exametazime and 123I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury. PLoS ONE. 9(1). e87009–e87009. 13 indexed citations
7.
Hamandi, Khalid, et al.. (2002). Irreversible damage to the spinal cord following spinal anesthesia. Neurology. 59(4). 624–626. 42 indexed citations
8.
Drees, Cornelia, Todd Lewis, & Sherif B. Mossad. (1999). CLINICAL ARTICLES. Clinical Infectious Diseases. 29(2). 276–278. 18 indexed citations
9.
Lewis, Todd, Anita S. Tesh, & Kenneth W. Lyles. (1999). Caring for the patient with Paget's disease of the bone.. PubMed. 24(7). 50, 53, 57–8 passim.
10.
Bruno, Richard L., et al.. (1996). BROMOCRIPTINE IN THE TREATMENT OF POST-POLIO FATIGUE. American Journal of Physical Medicine & Rehabilitation. 75(5). 340–347. 28 indexed citations
11.
Lewis, Todd. (1996). Simulation of Small Robotic Vehicle Performance During UXO Gathering Operations Using Discrete Event Control.. Calhoun: The Naval Postgraduate School Institutional Archive (Naval Postgraduate School). 2 indexed citations
12.
Bruno, Richard L., et al.. (1996). Polioencephalitis and the Brain Fatigue Generator Model of Post-Viral Fatigue Syndromes. Journal of Chronic Fatigue Syndrome. 2(2-3). 5–27. 9 indexed citations
13.
Lewis, Todd, et al.. (1986). Comparison of diflunisal and piroxicam in the management of patients with osteoarthritis.. PubMed. 9 Suppl C. 15–26. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026